MedTrace Logo

Induction of Ovulation by Clomiphene Citrate Following Laparoscopic Surgery for Endometriosis Stage 1 and Stage 2 With and Without Suppression by Dienogest

NCT02575248 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 310

Last updated 2017-06-22

No results posted yet for this study

Summary

This study aims at investigating the fertility outcome of endometriosis suppression with dienogest 2mg / day for 3 month followed by induction of ovulation for 3 month in endometriosis patients stage I and II.

Conditions

Interventions

DRUG

Dienogest 2mg

Dienogest 2mg is given daily for 3 months then followed by Clomiphene citrate 5 mg induction of ovulation for three months

DRUG

Clomiphene citrate 5 mg

Clomiphene citrate 5 mg for induction of ovulation for three months

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • laila fareed, lecturer · 01222148471

  • mostafa fouad, professor · 01226188993

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Egypt

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02575248 on ClinicalTrials.gov